Impact of <i>STAT6</i> Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

Impact of <i>STAT6</i> Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis

Proton pump inhibitors (PPIs) are the first-line drug for eosinophilic esophagitis (EoE), although it is estimated that there is a lack of histological remission in 50% of patients. This research aimed to identify pharmacogenetic biomarkers predictive of PPI effectiveness and to study their associat...

Full description

Bibliographic Details
Main Authors: Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J. Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J. Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubiaur
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
<i>STAT6</i>
pharmacogenetics
eosinophilic esophagitis
<i>CYP2C19</i>
Online Access:https://www.mdpi.com/1422-0067/25/7/3685

Internet

https://www.mdpi.com/1422-0067/25/7/3685

Similar Items